Skip to main content
Equibles

STATE STREET CORP

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 93751 BOSTON, MA
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$191,829,196
+$156,312,611 QoQ
Shares Held
12,996,558
+54.8% QoQ
Ownership
6.44%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 192 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 9% Shared 0% None 91%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. SLS ranks #48 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in SLS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $191,829,196 12,996,558
2026-03-31 $35,516,585 8,396,356
2025-12-31 $8,249,404 2,188,171
2025-09-30 $2,191,071 1,360,914
2025-06-30 $2,436,823 1,112,705
2025-03-31 $299,191 277,029
2024-12-31 $236,838 227,729
2024-09-30 $218,161 174,529
2024-06-30 $159,494 134,029
2024-03-31 $98,100 97,129
2023-12-31 $102,956 97,129
2023-09-30 $159,291 97,129
2023-06-30 $152,492 97,129
2023-03-31 $138,894 97,129
2022-12-31 $169,280 71,729
2022-09-30 $117,576 58,206
2022-06-30 $114,256 51,236
2022-03-31 $342,256 51,236
2021-12-31 $207,198 37,468
2021-09-30 $343,206 37,468
2021-06-30 $415,894 37,468